Login / Signup

First- and third-generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions.

Chirag VasavdaB K HoD Y ZhangK A WilliamsB H KaffenbergerShawn G KwatraM M Kwatra
Published in: The British journal of dermatology (2020)
Keyphrases
  • epidermal growth factor receptor
  • tyrosine kinase
  • advanced non small cell lung cancer
  • adverse drug
  • electronic health record